October 12, 2025Open Access

SARC-F as a Screening Tool in Rheumatoid Arthritis: Real-World Burden of Sarcopenia Risk, Sex Differences, and Clinical Correlates

View Full Paper

Ask AI

Bookmark

SARC-F identified a sarcopenia risk in 28.8% of rheumatoid arthritis patients, indicating a significant health concern.
Women with rheumatoid arthritis showed a higher burden of sarcopenia risk at 34% compared to age-matched controls at 24.7%, highlighting sex differences.
Observational case–control study involved 275 rheumatoid arthritis patients compared with 300 controls, assessing the burden of sarcopenia risk.
Incorporating SARC-F and grip strength testing may enhance the identification and management of sarcopenia in routine rheumatology practice.

Discussion

No takes yet. Share an insight, caveat, or question.

Observational study finds higher sarcopenia risk in women with rheumatoid arthritis using SARC-F, suggesting clinical implications.

Nolla et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark